Charlotte Schutz Selected Research

Charlotte Schutz Research Topics

Disease

30	Tuberculosis (Tuberculoses) 05/2024 - 03/2012
16	Cryptococcal Meningitis 12/2022 - 06/2012
8	Immune Reconstitution Inflammatory Syndrome 07/2023 - 10/2012
8	Infections 01/2023 - 06/2012
6	Inflammation (Inflammations) 01/2023 - 12/2014
4	Acquired Immunodeficiency Syndrome (AIDS) 11/2018 - 12/2015
3	Sepsis (Septicemia) 01/2022 - 01/2017
3	Neoplasms (Cancer) 11/2018 - 08/2016
2	Anemia 01/2023 - 12/2015
2	Body Weight (Weight, Body) 01/2022 - 06/2014
2	Coinfection 01/2021 - 01/2021
2	Pulmonary Tuberculosis 01/2021 - 01/2021
2	Meningitis 01/2019 - 01/2014
1	Critical Illness (Critically Ill) 01/2022
1	Fever (Fevers) 01/2021
1	Tachycardia (Tachyarrhythmias) 01/2021
1	Extrapulmonary Tuberculosis 01/2020
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019
1	Multi-centric Castleman's Disease 01/2019
1	Bacterial Infections (Bacterial Infection) 11/2018
1	HIV Infections (HIV Infection) 11/2018
1	Respiratory Insufficiency (Respiratory Failure) 03/2018
1	Pneumonia (Pneumonitis) 03/2018
1	Disseminated Intravascular Coagulation 01/2017
1	Necrosis 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Drug-Related Side Effects and Adverse Reactions 01/2013
1	Clinical Deterioration 01/2013
1	Cytokine Release Syndrome 10/2012
1	Vitamin D Deficiency 10/2012
1	Chemical and Drug Induced Liver Injury 03/2012
1	Liver Diseases (Liver Disease) 03/2012

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2023 - 10/2012
8	Rifampin (Rifampicin)FDA LinkGeneric 05/2024 - 01/2013
8	Prednisone (Sone)FDA LinkGeneric 05/2024 - 02/2013
8	lipoarabinomannan (LAM)IBA 01/2022 - 01/2017
6	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2022 - 06/2014
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
5	Fluconazole (Zonal)FDA LinkGeneric 01/2022 - 06/2014
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 10/2012
4	AntigensIBA 01/2023 - 01/2014
4	ChemokinesIBA 01/2023 - 10/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2012
3	liposomal amphotericin B FDA Link 01/2022 - 11/2018
3	deoxycholate drug combination amphotericin BIBA 01/2022 - 01/2017
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 10/2012
2	Flucytosine (Ancobon)FDA Link 01/2022 - 01/2019
2	InterleukinsIBA 01/2021 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 12/2015 - 12/2015
1	Levofloxacin (Levaquin)FDA Link 05/2024
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	AntibodiesIBA 01/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2022
1	Antitubercular AgentsIBA 01/2022
1	Pyrazinamide FDA LinkGeneric 01/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022
1	C-Reactive ProteinIBA 01/2021
1	Viral RNAIBA 11/2018
1	GlucocorticoidsIBA 11/2018
1	Hemostatics (Antihemorrhagics)IBA 01/2017
1	AnticoagulantsIBA 01/2017
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2017
1	ProcalcitoninIBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	glucuronoxylomannanIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2015
1	InflammasomesIBA 09/2015
1	Matrix Metalloproteinases (MMPs)IBA 12/2014
1	chinese inkIBA 01/2014
1	LatexIBA 01/2014
1	hydroxide ionIBA 10/2012
1	Vitamin D FDA LinkGeneric 10/2012
1	InterferonsIBA 06/2012
1	Alanine Transaminase (SGPT)IBA 03/2012
1	BilirubinIBA 03/2012

Therapy/Procedure

14	Therapeutics 01/2021 - 06/2012
10	Art Therapy 01/2019 - 03/2012
1	Treatment Delay 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Blood Transfusion (Blood Transfusions) 12/2015
1	Immunotherapy 06/2012